Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulation, 2015, please find the Newspaper publications of Unaudited ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kimia Biosciences Ltd has informed BSE that its unaudited standalone financial results for the quarter ended June 30, 2025 (Q1 FY26) have been published in newspapers as required by SEBI listing regulations. The results appeared in Financial Express (English edition, New Delhi) and Jansatta (Hindi edition, New Delhi). The filing was signed by Managing Director and CEO Sameer Goel on August 16, 2025. This is a routine compliance disclosure, and the actual financial numbers are contained in the newspaper clippings rather than this BSE letter.
This is a standard regulatory compliance filing and does not contain any new business or financial information on its own. No direct impact on share price is expected from this disclosure; investors should review the underlying Q1 results in the newspaper publications for any meaningful performance signals.